Lee Willis C's Form 4 filing
Emmaus Life Sciences, Inc. (EMMA) · filed Jun 3, 2022
- Accession no.
- 0001209191-22-033847
- Filed
- Jun 3, 2022, 11:52 AM ET
- Trade date
- May 27-31, 2022
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.93K. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lee Willis CCIK 0001517775 | Director, Officer (Director & COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 27, 2022 | Common stock, $0.001 par value | PPurchaseAcquired | +2,500 | $0.37 | +$925 | 281,274 | Direct | |
| May 31, 2022 | Common stock, $0.001 par value | PPurchaseAcquired | +2,500 | $0.40 | +$1,000 | 283,774 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.